 | Up a level |
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M.; Diehl, V; Engert, A; Borchmann, P (2020). Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825. Annals of oncology, 31(8), p. 1093. Elsevier 10.1016/j.annonc.2020.05.020
Schüring, A N; Fehm, T; Behringer, K; Goeckenjan, M; Wimberger, P; Henes, M; Henes, J; Fey, Martin; von Wolff, Michael (2018). Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Archives of gynecology and obstetrics, 297(1), pp. 241-255. Springer 10.1007/s00404-017-4594-3
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of oncology, 23(7), pp. 1818-25. Oxford: Oxford University Press 10.1093/annonc/mdr575
Behringer, K; von Wolff, M; Mead, B (2011). Gonadal dysfunction and fertility presercation in Hodgkin lymphoma (HL) patients. In: Andreas Engert, Sandra J. Horning (ed.) Hodgkin Lymphoma (pp. 345-354). Heidelberg: Springer Verlag
